first large study of glp-1 receptor agonists during pregnancy Glucagon-like peptide-1 agonist use in pregnancy: a review Frontiers | Exploring the multifaceted

Tesamorelin vs CJC-1295/Ipamorelin at a Glance Tesamorelin FDA Status FDA-approved (Egrifta, November 2010) CJC-1295/Ipam FDA Status Compounded (CJC-1295 reached Phase 2) Tesamorelin Mechanism GHRH receptor only (DPP-IV protected) CJC-1295/Ipam Mechanism GHRH + ghrelin receptor (dual pathway) Strongest Evidence Tesamorelin: 2 Phase 3 RCTs, 816 patients, CT-measured fat Most Popular CJC-1295/Ipamorelin (dual pathway, broader benefits) The Core Difference Tesamorelin and CJC-1295 both bind the GHRH receptor on pituitary somatotroph cells to stimulate growth hormone release

^Zhang S, Wang C, Zhong W, Kemp AH, Guo M, Killpartrick A

It appears that the glutathione level could turn out to be one of the premiere biological markers of aging

On the origin of prostaglandin and its role in the sympathetic nerve transmission in vas deferens

How to Pick the Right Dysphagia ICD-10 Code: A Three-Question Framework Choosing the dysphagia code comes down to three questions in order

Those populations with higher baseline liver fat or obesity experienced the greatest absolute changes